Otsuka, Alkermes Trade Fire Over Abilify Maintena Rival
Otsuka Pharmaceutical Co. Ltd. and Alkermes Inc. are in a tough war of words as the U.S. Food and Drug Administration weighs approval of an Alkermes product that would directly compete...To view the full article, register now.
Already a subscriber? Click here to view full article